1. Home
  2. NCRA vs CTXR Comparison

NCRA vs CTXR Comparison

Compare NCRA & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCRA
  • CTXR
  • Stock Information
  • Founded
  • NCRA 2002
  • CTXR 2007
  • Country
  • NCRA Taiwan
  • CTXR United States
  • Employees
  • NCRA N/A
  • CTXR N/A
  • Industry
  • NCRA Farming/Seeds/Milling
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCRA Consumer Staples
  • CTXR Health Care
  • Exchange
  • NCRA Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • NCRA 16.8M
  • CTXR 14.6M
  • IPO Year
  • NCRA N/A
  • CTXR N/A
  • Fundamental
  • Price
  • NCRA $1.02
  • CTXR $0.86
  • Analyst Decision
  • NCRA
  • CTXR Strong Buy
  • Analyst Count
  • NCRA 0
  • CTXR 3
  • Target Price
  • NCRA N/A
  • CTXR $54.50
  • AVG Volume (30 Days)
  • NCRA 132.9K
  • CTXR 153.2K
  • Earning Date
  • NCRA 05-15-2025
  • CTXR 05-14-2025
  • Dividend Yield
  • NCRA N/A
  • CTXR N/A
  • EPS Growth
  • NCRA N/A
  • CTXR N/A
  • EPS
  • NCRA N/A
  • CTXR N/A
  • Revenue
  • NCRA $16,647,379.00
  • CTXR N/A
  • Revenue This Year
  • NCRA N/A
  • CTXR N/A
  • Revenue Next Year
  • NCRA N/A
  • CTXR N/A
  • P/E Ratio
  • NCRA N/A
  • CTXR N/A
  • Revenue Growth
  • NCRA N/A
  • CTXR N/A
  • 52 Week Low
  • NCRA $0.70
  • CTXR $0.65
  • 52 Week High
  • NCRA $2.09
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • NCRA 50.34
  • CTXR 51.82
  • Support Level
  • NCRA $0.91
  • CTXR $0.80
  • Resistance Level
  • NCRA $1.25
  • CTXR $0.92
  • Average True Range (ATR)
  • NCRA 0.11
  • CTXR 0.08
  • MACD
  • NCRA -0.00
  • CTXR 0.03
  • Stochastic Oscillator
  • NCRA 22.29
  • CTXR 62.41

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: